Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Constellation Brands
STZ
5
Halozyme Therapeutics
HALO
(Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -13.99%105.04M | 29.84%452.86M | 12.13%107.88M | 65.68%117.56M | 8.13%105.3M | 44.97%122.13M | 64.63%348.78M | 36.52%96.21M | 26.00%70.96M | 108.62%97.38M |
Net interest income | 24.83%76.02M | 17.91%272.59M | 40.40%73.48M | 16.00%72.15M | 6.22%66.06M | 11.82%60.9M | 34.86%231.19M | -1.78%52.33M | 26.51%62.2M | 56.46%62.19M |
-Net interest income | 15.96%104.87M | 22.77%396.34M | 27.97%103.55M | 18.96%105.05M | 16.50%97.31M | 29.04%90.44M | 68.30%322.83M | 24.72%80.92M | 60.10%88.3M | 100.38%83.53M |
-Interest income from loans and lease | 15.98%98.15M | 22.26%372.02M | 30.89%96.87M | 19.05%99.59M | 13.40%90.94M | 27.38%84.62M | 65.96%304.29M | 20.88%74.01M | 59.86%83.65M | 99.67%80.2M |
-Interest income from deposits | 26.99%6.07M | 38.57%21.27M | 5.87%6.02M | 23.09%4.78M | 112.21%5.68M | 54.34%4.78M | 128.09%15.35M | 83.63%5.69M | 70.88%3.88M | 180.13%2.68M |
-Interest income from securities | -37.14%650K | -4.41%3.06M | -46.04%661K | -11.88%675K | 5.05%686K | 86.98%1.03M | 83.21%3.2M | 119.93%1.23M | 38.27%766K | 15.99%653K |
-Total interest expense | -2.34%28.85M | 35.03%123.75M | 5.19%30.07M | 26.01%32.89M | 46.47%31.25M | 89.09%29.54M | 349.35%91.64M | 146.47%28.59M | 335.76%26.1M | 1,003.78%21.34M |
-Interest expense for deposit | -2.36%28.19M | 35.88%120.93M | 5.33%29.4M | 26.06%32.08M | 47.90%30.58M | 92.99%28.87M | 368.32%89M | 152.38%27.92M | 345.18%25.45M | 1,135.80%20.68M |
-Interest expense for long term debt and capital securities | -1.49%659K | 6.54%2.82M | -0.45%667K | 24.27%809K | 1.66%672K | 1.06%669K | 90.08%2.64M | 24.77%670K | 138.46%651K | 154.23%661K |
-Other interest expense | --1K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Non interest income | -52.61%29.02M | 53.30%180.27M | -21.59%34.4M | 418.62%45.41M | 11.51%39.23M | 105.59%61.23M | 190.91%117.6M | 155.24%43.88M | 22.48%8.76M | 408.18%35.18M |
-Fees and commissions | -55.23%27.25M | 53.30%175.8M | -26.38%31.25M | 439.28%44.88M | 10.62%37.16M | 107.80%60.87M | 202.59%114.67M | 169.15%42.44M | 18.95%8.32M | 425.37%33.59M |
-Other non interest income | 454.55%1.71M | 100.05%4.01M | 150.59%2.96M | 67.01%486K | 50.32%1.89M | 3.01%308K | -14.09%2.01M | -8.30%1.18M | 11.92%291K | 218.18%1.26M |
-Gain loss on sale of assets | 6.67%16K | -94.92%27K | -98.75%1K | -98.21%2K | -94.94%9K | -90.74%15K | 447.71%532K | 544.44%80K | 184.21%112K | --178K |
-Dividend income | 8.11%40K | 12.40%435K | 11.05%191K | 13.79%33K | 11.54%174K | 23.33%37K | 12.17%387K | 14.67%172K | 20.83%29K | 16.42%156K |
Credit losses provision | 32.92%-55.78M | -50.88%-277.61M | -1.77%-61.87M | -157.80%-70.26M | -19.28%-62.33M | -90.31%-83.16M | -132.71%-183.99M | -80.92%-60.79M | -47.89%-27.25M | -270.75%-52.25M |
Non interest expense | 23.90%37.49M | 9.55%117.94M | 22.29%28.81M | 0.89%30.92M | -1.38%27.95M | 20.50%30.26M | 31.02%107.66M | 10.47%23.56M | 28.66%30.65M | 45.59%28.34M |
Occupancy and equipment | -31.88%1.03M | -5.66%3.94M | -273.72%-1.02M | 42.97%1.75M | 47.51%1.69M | 24.53%1.52M | -1.11%4.17M | -31.30%586K | 6.71%1.22M | 5.54%1.14M |
Professional expense and contract services expense | 76.69%6.49M | 4.75%15.51M | 73.88%4.61M | -19.11%3.6M | -21.83%3.63M | 19.92%3.67M | 118.98%14.8M | -5.36%2.65M | 97.56%4.45M | 363.57%4.65M |
Selling and administrative expenses | 15.44%23.08M | 4.73%75.55M | 6.99%16.71M | -3.55%19.82M | 3.84%19.03M | 13.29%19.99M | 25.42%72.14M | 7.39%15.62M | 23.46%20.55M | 31.35%18.33M |
-General and administrative expense | 20.20%22.92M | 5.51%75.06M | 10.17%19.43M | -4.71%18.4M | 4.41%18.17M | 13.52%19.07M | 25.25%71.14M | 14.03%17.63M | 21.98%19.31M | 29.16%17.4M |
-Selling and marketing expense | -82.97%157K | -51.20%487K | -34.87%-2.72M | 14.63%1.42M | -6.78%866K | 8.73%922K | 38.80%998K | -118.66%-2.02M | 52.53%1.24M | 92.34%929K |
Other non-interest expense | 35.70%6.89M | 38.69%22.95M | 80.85%8.52M | 29.91%5.76M | -14.77%3.6M | 59.47%5.08M | 21.04%16.55M | 50.26%4.71M | 17.20%4.43M | 23.25%4.23M |
Income from associates and other participating interests | ||||||||||
Special income (charges) | ||||||||||
Other non-operating income (expenses) | ||||||||||
Income before tax | 35.04%11.77M | 0.32%57.32M | 45.03%17.2M | 25.49%16.38M | -10.49%15.02M | -43.55%8.72M | 12.86%57.13M | -23.71%11.86M | -7.19%13.05M | 27.96%16.78M |
Income tax | 6.48%2.04M | -3.63%12.1M | 34.60%3.83M | 5.10%2.93M | -11.64%3.43M | -37.15%1.92M | 25.59%12.55M | 17.35%2.85M | -6.07%2.78M | 31.88%3.88M |
Earnings from equity interest net of tax | ||||||||||
Net income | 43.09%9.73M | 1.44%45.22M | 48.32%13.37M | 31.02%13.46M | -10.15%11.6M | -45.12%6.8M | 9.73%44.58M | -31.30%9.01M | -7.49%10.27M | 26.83%12.91M |
Net Income continuous operations | 43.09%9.73M | 1.44%45.22M | 48.32%13.37M | 31.02%13.46M | -10.15%11.6M | -45.12%6.8M | 9.73%44.58M | -31.30%9.01M | -7.49%10.27M | 26.83%12.91M |
Minority interest income | ||||||||||
Net income attributable to the parent company | 43.09%9.73M | 1.44%45.22M | 48.32%13.37M | 31.02%13.46M | -10.15%11.6M | -45.12%6.8M | 9.73%44.58M | -31.30%9.01M | -7.49%10.27M | 26.83%12.91M |
Preferred stock dividends | ||||||||||
Other preferred stock dividend | ||||||||||
Net income attributable to common stockholders | 43.09%9.73M | 1.44%45.22M | 48.32%13.37M | 31.02%13.46M | -10.15%11.6M | -45.12%6.8M | 9.73%44.58M | -31.30%9.01M | -7.49%10.27M | 26.83%12.91M |
Basic earnings per share | 27.45%0.65 | -0.30%3.35 | 42.65%0.97 | 29.87%1 | -11.34%0.86 | -45.74%0.51 | 7.01%3.36 | -32.67%0.68 | -10.47%0.77 | 22.78%0.97 |
Diluted earnings per share | 26.00%0.63 | -0.31%3.26 | 42.42%0.94 | 29.33%0.97 | -11.58%0.84 | -45.05%0.5 | 8.64%3.27 | -31.25%0.66 | -8.54%0.75 | 25.00%0.95 |
Dividend per share | ||||||||||
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |